Meditera - Public Comps and Valuation Multiples

Meditera Overview

About Meditera

MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.

Founded

1996

HQ

Employees

n/a

Website

meditera.com.tr

Sectors

Medical Devices
Medical Supplies
HealthTech
DeepTech

Financials

LTM Revenue $59.9M

LTM EBITDA $11.6M

EV

$96.9M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Meditera Financials

Meditera has a last 12-month revenue of $59.9M and a last 12-month EBITDA of $11.6M.

In the most recent fiscal year, Meditera achieved revenue of $55.1M and an EBITDA of $6.2M.

Meditera expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Meditera valuation multiples based on analyst estimates

Meditera P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$38.2M	$55.1M	XXX	XXX	XXX
Gross Profit	$9.8M	$16.9M	XXX	XXX	XXX
Gross Margin	26%	31%	XXX	XXX	XXX
EBITDA	$4.2M	$6.2M	XXX	XXX	XXX
EBITDA Margin	11%	11%	XXX	XXX	XXX
Net Profit	$7.8M	$0.7M	XXX	XXX	XXX
Net Margin	20%	1%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Meditera Stock Performance

As of April 21, 2025, Meditera's stock price is TRY 34 (or $1).

Meditera has current market cap of TRY 4.1B (or $107M), and EV of TRY 3.7B (or $96.9M).

See Meditera trading valuation data

Meditera Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$96.9M	$107M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Meditera Valuation Multiples

As of April 21, 2025, Meditera has market cap of $107M and EV of $96.9M.

Meditera's trades at 1.6x LTM EV/Revenue multiple, and 8.3x LTM EBITDA.

Analysts estimate Meditera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Meditera and 10K+ public comps

Meditera Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$96.9M	XXX	XXX	XXX
EV/Revenue	1.8x	XXX	XXX	XXX
EV/EBITDA	15.7x	XXX	XXX	XXX
P/E	55.4x	XXX	XXX	XXX
P/E/Growth	0.4x	XXX	XXX	XXX
EV/FCF	9.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Meditera Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Meditera Valuation Multiples

Meditera's NTM/LTM revenue growth is 28%

Meditera's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Meditera's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Meditera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Meditera and other 10K+ public comps

Meditera Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	44%	XXX	XXX	XXX	XXX
EBITDA Margin	11%	XXX	XXX	XXX	XXX
EBITDA Growth	46%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	40%	XXX	XXX	XXX	XXX
Revenue per Employee	n/a	XXX	XXX	XXX	XXX
Opex per Employee	n/a	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	4%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	5%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	1%	XXX	XXX	XXX	XXX
Opex to Revenue	28%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Streaming Platforms

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Explore Valuation Multiples by Industry